J&J Covid-19 vaccine no longer available in the US
The Covid-19 vaccine from Johnson & Johnson is no longer available in the United States, according to the US Centers for Disease Control and Prevention.
All remaining doses expired last week, and the CDC directed providers to dispose of any that they had left over.
About 19 million people in the US have received the J&J vaccine since it first became available. But more than 31.5 million doses have been delivered to states and other jurisdictions, leaving about 12.5 million doses unused, according to CDC data.
Last year, the CDC limited the emergency use authorization of the vaccine to adults for whom other vaccines aren’t appropriate or accessible due to risk of a rare and dangerous clotting condition called thrombosis with thrombocytopenia syndrome (TTS) after receiving the vaccine.
Only about 7% of people who are vaccinated in the US got the J&J vaccine as their first shot.
The mRNA vaccines from Pfizer/BioNTech and Moderna represented the vast majority of shots administered. Now that the Covid-19 Public Health Emergency is over in the US, these vaccines remain free as long as federal supplies last.
More Stories
Bottled water sales up 67 per cent after Be Ready campaign launch
Sales of bottled water rose 67 per cent and hand sanitiser 83 per cent in the 10 days after the...
Ancep raises $8.5m to help brokers place the risks they turn away
Ancep, a London company that builds AI agents for commercial insurance brokers, has raised $8.5m in a funding round led...
Nearly half of £8.2bn R&D tax relief goes to London and South East firms
Companies registered in London and the South East claimed almost half of the £8.2bn of research and development tax relief...
Spain eyes TikTok shutdown over 20,000 suspected pedophile profiles
The country’s Youth Ministry has asked for a probe after a report documented 1,182 public posts containing child sexual abuse...
Russia to build $8 bn metals hub in Far East
The project in Khabarovsk Region will supply iron ore products to markets in China, India, and Indonesia Russia is set...
Mars to spend £161m on Melton Mowbray pet food factory
Mars, the maker of Pedigree and Whiskas, is to spend £161m modernising its 75-year-old pet food factory in Melton Mowbray,...
